BANGOR — A Surry man was sentenced Tuesday to serve two years in federal prison for “holding for sale counterfeit drugs,” in a case brought by the U.S. Food and Drug Administration’s Office of Criminal Investigation, federal prosecutors said.
U.S. District Judge John A. Woodcock Jr. also sentenced Adam Fitzherbert, 55, to three years of probation after his release from prison, U.S. Attorney Halsey B. Frank announced in a press release Wednesday.
Fitzherbert pleaded guilty on Sept. 3, 2019.
According to court records, on Feb. 6, 2018, Fitzherbert was arrested at his residence in Surry while agents were executing a search warrant there.
While executing the warrant, FDA agents recovered 91 counterfeit Oxycodone HCL pills from Fitzherbert’s bedroom that were later found to contain carfentanil. Fitzherbert admitted purchasing the pills through a “dark web” marketplace, Frank stated.
“The opioid epidemic that has resulted in overdoses and deaths is a national public health crisis. Those who contribute to that crisis by illicitly distributing opioids, whether online or through conventional drug distribution methods, will be brought to justice,” said Special Agent in Charge Jeffrey J. Ebersole of the FDA Office of Criminal Investigations’ New York field office.
“The FDA is fully committed to disrupting and dismantling networks engaged in the manufacturing and sale of illicit opioids and counterfeit prescription drugs. We will continue to pursue and bring to justice those who threaten the health and safety of Americans by distributing dangerous products.”
The FDA’s Office of Criminal Investigations, the Maine Drug Enforcement Agency, the Maine State Police, the Hancock County Sheriff’s Office and the Ellsworth Police Department investigated the case. The U.S. Attorney’s Office prosecuted the case as part of the Department of Justice’s Strategy to Combat the Opioid Epidemic.